Survival Benefits of Neoadjuvant Chemotherapy Followed by Radical Surgery versus Radiotherapy in Locally Advanced Chemoresistant Cervical Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Survival Benefits of Neoadjuvant Chemotherapy Followed by Radical Surgery versus Radiotherapy in Locally Advanced Chemoresistant Cervical Cancer

Published:2006 Issue:4 Volume:21 Page:683
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:
Short-container-title:J Korean Med Sci

Author:

Choi Youn Seok¹,Sin Jeong-Im²,Kim Ju Hyun¹,Ye Gi Won³,Shin Im Hee⁴,Lee Tae Sung¹

Affiliation:

1. Department of Obstetrics and Gynecology, Catholic University of Daegu, Daegu, Korea.

2. Department of Microbiology, Catholic University of Daegu, Daegu, Korea.

3. Department of Radiation Oncology, Catholic University of Daegu, Daegu, Korea.

4. Department of Medical Statistics, Catholic University of Daegu, Daegu, Korea.

Publisher

Korean Academy of Medical Sciences

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.3346/jkms.2006.21.4.683

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment options for neoadjuvant strategies of esophageal squamous cell carcinoma (Review);Molecular and Clinical Oncology;2023-11-20

2. Neoadjuvant chemotherapy for locally advanced stage (IB2-IIA2-IIB) cervical carcinoma: Experience of a tertiary center and comprehensive review of the literature;Journal of Turkish Society of Obstetric and Gynecology;2021-09-27

3. Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer—A Propensity Score Matching Analysis;Frontiers in Oncology;2021-09-13

4. Prognostic significance of the Central Tumor Size (CTS) in Cervical Cancer (CC) stages IIb and IIIb: What should we do with the FIGO staging system and therapeutic strategies?;Archives of Cancer Science and Therapy;2021-03-17

5. Resveratrol suppresses the growth and metastatic potential of cervical cancer by inhibiting STAT3 Tyr705 phosphorylation;Cancer Medicine;2020-10-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3